Search results
Novavax's COVID-19 Vaccine Gets Complete Approval From European Commission
Benzinga via Yahoo Finance· 10 months agoThe European Commission has approved Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373), following...
Novavax Inc (NVAX) Reports Mixed Q3 Results Amid Cost Reduction Efforts and Vaccine Approvals
GuruFocus.com via Yahoo Finance· 6 months agoNovavax Inc (NASDAQ:NVAX) reported total revenue of $187 million for Q3 2023, a significant decrease...
Novavax's (NVAX) COVID Jab Gets Full Approval in Europe
Zacks via Yahoo Finance· 10 months agoNovavax NVAX announced that the European Commission had granted full marketing authorization for its...
Novavax (NVAX) Gets EU Nod for COVID-19 Booster Jab in Adults
Zacks via Yahoo Finance· 2 years agoNovavax NVAX announced that the European Commission (EC) expanded its conditional marketing...
Europe Approves Novavax's COVID-19 Vaccine Booster For Adults
Benzinga via Yahoo Finance· 2 years agoThe European Commission has approved the expanded conditional approval of Novavax Inc's (NASDAQ:...
Why Novavax Stock Is Plunging This Week
Motley Fool· 2 years agoWhat happened Shares of Novavax (NASDAQ: NVAX) were plunging 26.3% this week as of the market close on Thursday, according to data provided by S&P Global...
Why Shares of Novavax Are Up Monday
Motley Fool· 10 months agoShares of Novavax (NASDAQ: NVAX) were up more than 24% as of 12:08 p.m. ET on Monday after the biotech company said Friday that Canada will pay $349.6...
Health Canada authorizes Novavax's updated COVID shot for Omicron
Reuters via AOL· 5 months agoLast month, WHO granted emergency-use authorization to the vaccine, which targets a descendant of...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 14 hours agoPfizer stock is trading near an 11-year low as the drugmaker looks for its next big break after...
The FDA May Decide on Novavax's Vaccine Next Week: Here's What You Need to Know
Motley Fool· 2 years agoIt's the moment investors in Novavax (NASDAQ: NVAX) have been waiting for. A Food and Drug...
